Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference32 articles.
1. 11 years’ follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial;Cameron;Lancet,2017
2. Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer;Prat;J Natl Cancer Inst,2014
3. Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumours in HER2-positive breast cancer;Lee;Breast Cancer Res Treat,2014
4. Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study;Vaz-Luis;Breast Cancer Res,2012
5. Breast MRI: state of the art;Mann;Radiology,2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3